Liver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight

Summary

DelveInsight projects the liver cirrhosis market will expand significantly through 2036, driven by rising prevalence of chronic liver diseases and an emerging pipeline of novel therapies. The article discusses market growth drivers including hepatitis B, hepatitis C, alcohol-associated liver disease, and MASLD.